Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20140729001Phase 1Completed
Phase 1, single-arm trial of ketum, sponsored by National Science and Technology Development Agency. Primary endpoints: Pharmacokinetic parameters of kratom and Effects of kratom on electroencephalogram (EEG). Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20140729001.